Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy
In our study, the use of augmentation therapy post-LT was associated with improved survival. Confirmatory prospective studies should be considered to inform post-LT AAT therapy guidelines.
Authors
- Alfred J. Casillan (ORCID: https://orcid.org/0000-0001-7616-4368)
- Atharv Oak (ORCID: https://orcid.org/0000-0003-1441-520X)
- Christian A. Merlo (ORCID: https://orcid.org/0000-0002-9283-3928)
- Allan B. Massie (ORCID: https://orcid.org/0000-0002-5288-5125)
- Dorry Lidor Segev (ORCID: https://orcid.org/0000-0002-1924-4801)
- Ramon Riojas (ORCID: https://orcid.org/0000-0002-5486-6243)
- Jessica M. Ruck (ORCID: https://orcid.org/0000-0002-5749-5505)
- Jinny S Ha (ORCID: https://orcid.org/0000-0003-1044-8186)
- Sara Strout (ORCID: https://orcid.org/0000-0002-9345-9894)
- Errol L. Bush (ORCID: https://orcid.org/0000-0003-1251-8467)
- Armaan F. Akbar (ORCID: https://orcid.org/0000-0002-4255-9019)
- Pali D. Shah
Institutions
- National Marrow Donor Program (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- NYU Langone Health (US)
- New York University (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1016/j.jhlto.2024.100201
- Citations
- 1
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Hennepin Healthcare Research Institute
- National Institute on Aging
- National Institute of Diabetes and Digestive and Kidney Diseases